Seasonal Affective Disorder (SAD), often called "winter depression," is a type of depression that follows a seasonal pattern. Typically, symptoms emerge during the fall and winter months when daylight hours decrease.
Nov 6, 2024Initially developed for diabetes management, SGLT2 inhibitors have demonstrated benefits for heart health and overall mortality reduction. While the exact mechanisms are still unclear, emerging evidence suggests a link to senescent cell clearance. By potentially ridding the body of these harmful cells, SGLT2 inhibitors may contribute to improved health and longevity.
A T2D diagnosis can be overwhelming, but you don't have to face it alone. There are many resources available from healthcare providers including doctors and dieticians, as well as community programs, support groups, online resources and many more. Remember, these changes don't have to happen overnight. Gradually incorporating small adjustments into your life can lead to significant improvements over time.
When deciding between Victoza and Ozempic for managing type 2 diabetes, key factors to consider include their effectiveness in lowering blood sugar levels, potential for weight loss, dosing frequency, and possible side effects. While both medications belong to the same class of GLP-1 agonists, they differ in their administration schedules and specific benefits.
Metformin works by decreasing sugar production in the liver, decreasing absorption of sugars in your digestive tract, and increases uptake of sugars to your muscle, thus improving insulin sensitivity.
Have you heard of medications like Jardiance, Farxiga, or Brenzavvy? These drugs belong to a class called SGLT2 inhibitors, which have gained significant popularity in recent years for managing type 2 diabetes.
Teva Pharmaceuticals launched the first generic GLP-1 receptor agonist, an authorized generic version of Victoza, in June 2024. While expected to increase access, initial price reductions may be limited compared to typical generics.
Tradjenta, a dipeptidyl peptidase-4 (DPP-4) inhibitor, offers a targeted approach to managing type 2 diabetes. By elevating the levels of incretin hormones in the body, Tradjenta effectively reduces blood sugar levels, providing a valuable therapeutic option for adults with type 2 diabetes.
Farxiga and Brenzavvy help lower blood sugar levels by removing excess sugar through urination. Normally, the kidneys filter sugar out of the blood and reabsorb it back into the bloodstream. However, SGLT2 inhibitors like Farxiga and Brenzavvy block this reabsorption process. This means that instead of the sugar being reabsorbed, it is expelled from the body through urine. As a result, blood sugar levels decrease, which can also improve longer-term measures such as A1C levels.
DPP-4 inhibitors enhance the action of incretin hormones essential for lowering blood sugar levels by inhibiting the DPP-4 enzyme, which is responsible for their breakdown. This action increases the hormones' presence and activity, helping to manage blood sugar levels more effectively.
Regular diabetic eye exams are crucial for maintaining eye health in individuals with diabetes. Even if your general doctor conducts routine eye checks, it is essential to undergo a comprehensive eye exam every 1 to 2 years with an ophthalmologist or optometrist.
Januvia and Tradjenta are oral diabetic medications that belong to the same drug class known as DPP-4 inhibitors, used either as monotherapy or in combination with metformin to treat type 2 diabetes mellitus. While both medications regulate blood sugar levels by working in a similar manner, there are differences between them. This is why physicians carefully evaluate each patient's unique situation to determine the most appropriate medication.
Glipizide belongs to a group of drugs called sulfonylureas. These drugs are designed to help manage type 2 diabetes by interacting with the body's natural processes for controlling blood sugar.
Glimepiride is a medication specifically designed for managing type 2 diabetes. It's often used in combination with lifestyle changes like a healthy diet and regular exercise. Though it's an older drug, it can be particularly useful for certain individuals, especially when other diabetes medications aren't suitable.
If you're adhering to the prescribed Metformin regimen and lifestyle adjustments but still experience high blood sugar, it might indicate the need for an additional medication. The selection of this next treatment option will be based on its effectiveness, potential side effects, tolerability, and cost.
Choosing the right medication for type 2 diabetes can be challenging due to the variety of options available. BRENZAVVY and JANUVIA are two commonly considered medications, each with distinct differences. But which one is the better choice for you?
Metformin and Jardiance are both effective for managing type 2 diabetes, but they have different uses and side effects. Your doctor might suggest using both together, especially if Metformin alone isn't enough. It's important to discuss with your healthcare provider to find the best treatment for your specific needs. Remember, the right medication can vary for each person.
Among the medications used to treat type 2 diabetes, two key classes are DPP-4 inhibitors and SGLT2 inhibitors. Understanding how these drugs work is vital for both patients and healthcare providers. DPP-4 Inhibitors enhance the body's natural ability to lower blood sugar levels. They work by helping the body produce more insulin and reduce the production of glucose in the liver. SGLT2 Inhibitors assist the kidneys in removing excess glucose through urine. They do this by preventing glucose from being reabsorbed back into the blood from the kidneys.
Inpefa, known as Sotagliflozin, is a prescription medication to manage type 2 diabetes by regulating blood glucose levels. Clinical trials have suggested that Inpefa also offers cardiovascular advantages. These studies have shown a significant reduction in the risk of death and hospitalizations related to heart failure, highlighting its potential in managing cardiovascular aspects of diabetes.
Steglatro is an FDA-approved medication for managing type 2 diabetes in adults. It contains the active ingredient ertugliflozin, which belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, typically identified by the suffix "-gliflozin."
Selecting the right medication for type 2 diabetes can be challenging, given the multitude of choices available. Among these options, sodium-glucose cotransporter-2 (SGLT2) inhibitors are often on the table for consideration. However, the question remains: Which SGLT2 inhibitor is the best fit for you?